Finding the Missing Tuberculosis Patients.

J Infect Dis

Bill & Melinda Gates Foundation, Seattle, Washington.

Published: November 2017

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853462PMC
http://dx.doi.org/10.1093/infdis/jix368DOI Listing

Publication Analysis

Top Keywords

finding missing
4
missing tuberculosis
4
tuberculosis patients
4
finding
1
tuberculosis
1
patients
1

Similar Publications

Analysis of resting state fMRI (rs-fMRI) typically excludes images substantially degraded by subject motion. However, data quality, including degree of motion, relates to a broad set of participant characteristics, particularly in pediatric neuroimaging. Consequently, when planning quality control (QC) procedures researchers must balance data quality concerns against the possibility of biasing results by eliminating data.

View Article and Find Full Text PDF

Introduction: Driving safety may be compromised in people with dementia or mild cognitive impairment (MCI). Occupational therapists assess and screen for driving safety in older people with cognitive impairment. However, little is known about their perspectives relating to these assessments.

View Article and Find Full Text PDF

Background: Persons with disabilities are at higher risk of experiencing intimate partner violence (IPV) during the perinatal period than persons without disabilities. Although screening for IPV during the perinatal period is recommended by many organizations, little is known about screening rates for IPV by disability status.

Methods: Our objective was to compare rates of IPV screening during the perinatal period among persons with and without disabilities in the United States.

View Article and Find Full Text PDF

Aim: To explore nurses' perceptions of reasons for missed nursing care.

Design: A multicentre qualitative descriptive study was undertaken from August 2022 to January 2023.

Methods: Interpretive description methodology was used.

View Article and Find Full Text PDF

Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.

Lancet Gastroenterol Hepatol

January 2025

The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:

Background: Infliximab and adalimumab are the only biologics thus far approved for paediatric patients with inflammatory bowel disease (IBD), so other biologics, such as vedolizumab, are prescribed off-label. Despite its frequent use, prospective data for vedolizumab treatment in children are available only for short-term induction outcomes. We aimed to evaluate the long-term efficacy and safety of maintenance therapy with vedolizumab in paediatric patients with IBD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!